>
Adherium logo

ADR - Adherium Share Price

A$0.016 -0.0  -5.9%

Last Trade - 16/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £6.11m
Enterprise Value £6.01m
Revenue £600k
Position in Universe 1714th / 1898
Bullish
Bearish
Unlock ADR Revenue
Momentum
Relative Strength (%)
1m -26.7%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -68.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
2.91 3.19 2.96 6.17 2.85 2.23 -5.1%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020, AdheriumLtd revenues decreased 82% to A$253K. Net loss increased91% to A$8.6M. Revenues reflect Sales decrease of 83% toA$243K. Higher net loss reflects Administrative expensesincrease from A$1.7M to A$3.9M (expense), Research andDevelopment costs increase of 92% to A$3.5M (expense), FVAdjustments of Financial Investments decrease from A$562K(income) to A$108K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ADR Revenue Unlock ADR Revenue

Net Income

ADR Net Income Unlock ADR Revenue

Normalised EPS

ADR Normalised EPS Unlock ADR Revenue

PE Ratio Range

ADR PE Ratio Range Unlock ADR Revenue

Dividend Yield Range

ADR Dividend Yield Range Unlock ADR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ADR EPS Forecasts Unlock ADR Revenue
Profile Summary

Adherium Limited is principally engaged in the development, manufacture and supply of its Smartinhaler digital health technologies, which address sub-optimal medication use and improve health outcomes in chronic disease. It offers a range of smart devices for respiratory medications globally. Its Smartinhaler platform supports asthma and chronic obstructive pulmonary disease (COPD) medication adherence solution. The Bluetooth enabled Smartinhaler medication sensors wrap around patients existing inhalers and automatically send usage data to their smartphone. The Smartinhaler application enables patients and healthcare professionals to track medication adherence, set daily reminders, and discover insights into their medication usage. Its application also enables real-time reporting, monitoring, storing and analysis of inhaler use. The SmartinhalerLive platform uses wireless communications technology to provide real time data collection and reporting from the its Smartinhalers.

Directors
Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated April 17, 2015
Public Since August 26, 2015
No. of Shareholders: 680
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 679,596,011
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ADR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ADR
Upcoming Events for ADR
Frequently Asked Questions for Adherium
What is the Adherium share price?

As of 16/04/21, shares in Adherium are trading at A$0.016, giving the company a market capitalisation of £6.11m. This share price information is delayed by 15 minutes.

How has the Adherium share price performed this year?

Shares in Adherium are currently trading at A$0.016 and the price has moved by -46.67% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Adherium price has moved by -60.19% over the past year.

What are the analyst and broker recommendations for Adherium?

Of the analysts with advisory recommendations for Adherium, there are there are currently 0 "buy" , 0 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Adherium is Strong Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Adherium next release its financial results?

Adherium is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Adherium dividend yield?

Adherium does not currently pay a dividend.

Does Adherium pay a dividend?

Adherium does not currently pay a dividend.

When does Adherium next pay dividends?

Adherium does not currently pay a dividend.

How do I buy Adherium shares?

To buy shares in Adherium you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Adherium?

Shares in Adherium are currently trading at A$0.016, giving the company a market capitalisation of £6.11m.

Where are Adherium shares listed? Where are Adherium shares listed?

Here are the trading details for Adherium:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: ADR
What kind of share is Adherium?

Based on an overall assessment of its quality, value and momentum, Adherium is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Adherium share price forecast 2021?

Shares in Adherium are currently priced at A$0.016. At that level they are trading at 37.5% premium to the analyst consensus target price of 0.00.

How can I tell whether the Adherium share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Adherium. Over the past six months, the relative strength of its shares against the market has been -53.15%. At the current price of A$0.016, shares in Adherium are trading at -37.52% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Adherium PE Ratio?

We were not able to find PE ratio data for Adherium.

Who are the key directors of Adherium?

Adherium's management team is headed by:

Jeremy Curnock-Cook - NED
Bruce McHarrie - NID
Rob Turnbull - VFN
Nigel Devine - OTH
William Hunter - NED
Julia Chambers - OTH
Vik Panda - VPR
Timothy Houchin - VPR
Matthew McNamara - NED
Michael Motion - CEO
Jane Lapon - OTH
James Ward-Lilley - CHM
Anne Bell - CFO
Geoff Feakes - CTO
Who are the major shareholders of Adherium?

Here are the top five shareholders of Adherium based on the size of their shareholding:

Phillip Asset Management Limited Investment Advisor
Percentage owned: 19.62% (166.7m shares)
Trudell Medical Ltd. Corporation
Percentage owned: 19.47% (165.4m shares)
Regal Funds Management Pty. Ltd. Hedge Fund
Percentage owned: 6.21% (52.7m shares)
One Funds Management Ltd. Corporation
Percentage owned: 5.75% (48.8m shares)
FIL Investment Management (Hong Kong) Limited Investment Advisor
Percentage owned: 5.2% (44.2m shares)
Similar to ADR
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.